EMPAA M XR 12.5/1000MG TAB

EMPAA M XR is a combination tablet containing Empagliflozin 12.5mg and Metformin 1000mg. This extended-release formulation is designed to help manage type 2 diabetes by improving blood sugar control through dual mechanisms of action. Empagliflozin works by increasing glucose excretion through urine, while Metformin reduces glucose production in the liver and improves insulin sensitivity. The XR formulation allows for convenient once-daily dosing, supporting better medication adherence. Suitable for patients requiring combination therapy to achieve optimal glycemic control. Always use as directed by your healthcare provider.